|
⚲
|
| NAPO Pharmaceuticals Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001188290 |
| Sale | 2009-05-12 ($0.5 M Offered, $0.5 M Sold) |
| Fund | |
| Phone | 6506161900 |
| Address | 250 E Grand Avenue South San Francisco, 94080 |
| Source | [EDGAR] |
| Fund AUM and Sold ($k) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Steven King | |
| Charles Thompson | |
| Lisa Conte | |
| Sir William Young | |
| Jack van Hulst | |
| Pravin Chaturvedi | |
| Thomas van Dyck | |
| Gregory Stock |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Shanghai Pudong Science & Technology Investment Group Co., L
✚
|
0.0 | |
|
Shanghai Science & Technology Venture Capital (Group) Co., L
✚
|
0.0 | |
|
Shanghai Yuyun Management Partnership
✚
|
0.0 | |
|
Shannon Wendy S
✚
|
0.0 | |
|
Shao Mengshu
✚
|
0.0 | |
|
Shapiro Daniel
✚
|
0.0 | |
|
Sharafeldin Khaled
✚
|
0.0 | |
|
ShareBear Burst VIII, a series of ShareBear Ventures, LP
✚
|
0.0 | |
|
Sharett Anthony M.
✚
|
0.0 | |
|
Shaner William James
✚
|
0.0 |